Genexa Granted Temporary Exception to Import Kids’ Pain & Fever into Canada to Help Alleviate Ongoing Medication Shortages
Genexa, a clean medicine company, has received a temporary exception from Health Canada to import a limited amount of Kids’ Pain & Fever medication from its supply network in the United States. This medication is designed to temporarily reduce fever and alleviate a range of cold and flu symptoms in children between the ages of 2 and 11. Genexa has announced that it will make this product available in major Canadian retailers for a limited time to help alleviate the current shortage of children’s pain medication in the country.
David Johnson, Genexa’s CEO and Co-Founder stated that the company is proud to support Canadian families and children and is committed to assisting its neighbours to the North. The company is working closely with Health Canada to obtain long-term approval for its product and to introduce additional formulations and products in Canada.
